FDA NDC Directory · JSON-LD · Markdown
NDC 0121-0770 · HUMAN PRESCRIPTION DRUG · LIQUID
| Labeler / Manufacturer | Pharmaceutical Associates, Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA090260 |
| Dosage form / route | LIQUID · ORAL |
| Active ingredients | LORAZEPAM (2 mg/mL) |
| Marketing started | 20101101 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).